UniProt ID | MTMRE_HUMAN | |
---|---|---|
UniProt AC | Q8NCE2 | |
Protein Name | Myotubularin-related protein 14 | |
Gene Name | MTMR14 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 650 | |
Subcellular Localization | Cytoplasm . Found in reticular structures and plasma membrane ruffles. Concentrated near the nucleus. | |
Protein Description | Lipid phosphatase which efficiently dephosphorylates phosphatidylinositol 3-phosphate (PtdIns3P) and PtdIns(3,5)P2; inactive toward PtdIns4P, PtdIns(3,4)P2, PtdIns(4,5)P2 and PtdIns(3,4,5)P3.. | |
Protein Sequence | MAGARAAAAAASAGSSASSGNQPPQELGLGELLEEFSRTQYRAKDGSGTGGSKVERIEKRCLELFGRDYCFSVIPNTNGDICGHYPRHIVFLEYESSEKEKDTFESTVQVSKLQDLIHRSKMARCRGRFVCPVILFKGKHICRSATLAGWGELYGRSGYNYFFSGGADDAWADVEDVTEEDCALRSGDTHLFDKVRGYDIKLLRYLSVKYICDLMVENKKVKFGMNVTSSEKVDKAQRYADFTLLSIPYPGCEFFKEYKDRDYMAEGLIFNWKQDYVDAPLSIPDFLTHSLNIDWSQYQCWDLVQQTQNYLKLLLSLVNSDDDSGLLVHCISGWDRTPLFISLLRLSLWADGLIHTSLKPTEILYLTVAYDWFLFGHMLVDRLSKGEEIFFFCFNFLKHITSEEFSALKTQRRKSLPARDGGFTLEDICMLRRKDRGSTTSLGSDFSLVMESSPGATGSFTYEAVELVPAGAPTQAAWRKSHSSSPQSVLWNRPQPSEDRLPSQQGLAEARSSSSSSSNHSDNFFRMGSSPLEVPKPRSVDHPLPGSSLSTDYGSWQMVTGCGSIQERAVLHTDSSLPFSFPDELPNSCLLAALSDRETRLQEVRSAFLAAYSSTVGLRAVAPSPSGAIGGLLEQFARGVGLRSISSNAL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
47 | Phosphorylation | QYRAKDGSGTGGSKV CCCCCCCCCCCCHHH | 43.23 | - | |
49 | Phosphorylation | RAKDGSGTGGSKVER CCCCCCCCCCHHHHH | 39.81 | - | |
52 | Phosphorylation | DGSGTGGSKVERIEK CCCCCCCHHHHHHHH | 34.57 | - | |
101 | Ubiquitination | YESSEKEKDTFESTV ECCCHHHCCCHHHHH | 73.47 | - | |
106 | Phosphorylation | KEKDTFESTVQVSKL HHCCCHHHHHHHHHH | 29.68 | 23403867 | |
107 | Phosphorylation | EKDTFESTVQVSKLQ HCCCHHHHHHHHHHH | 14.04 | 23403867 | |
112 | Ubiquitination | ESTVQVSKLQDLIHR HHHHHHHHHHHHHHH | 51.84 | - | |
120 | Phosphorylation | LQDLIHRSKMARCRG HHHHHHHHHHHHCCC | 16.78 | 26074081 | |
154 | Phosphorylation | LAGWGELYGRSGYNY CCCHHHHHCCCCCCE | 13.24 | 29978859 | |
194 | Malonylation | GDTHLFDKVRGYDIK CCCCHHHHCCCCCHH | 26.88 | 26320211 | |
194 | Ubiquitination | GDTHLFDKVRGYDIK CCCCHHHHCCCCCHH | 26.88 | 21890473 | |
194 | Acetylation | GDTHLFDKVRGYDIK CCCCHHHHCCCCCHH | 26.88 | 19608861 | |
201 | Ubiquitination | KVRGYDIKLLRYLSV HCCCCCHHHHHHHCH | 38.27 | - | |
210 | Phosphorylation | LRYLSVKYICDLMVE HHHHCHHHHHHHHCC | 12.48 | - | |
226 | N-linked_Glycosylation | KKVKFGMNVTSSEKV CCEEEECCCCCHHHC | 34.00 | UniProtKB CARBOHYD | |
228 | Phosphorylation | VKFGMNVTSSEKVDK EEEECCCCCHHHCCH | 22.87 | 24505115 | |
409 (in isoform 2) | Ubiquitination | - | 42.18 | 21890473 | |
409 (in isoform 1) | Ubiquitination | - | 42.18 | 21890473 | |
409 (in isoform 3) | Ubiquitination | - | 42.18 | 21890473 | |
409 | Ubiquitination | SEEFSALKTQRRKSL HHHHHHHHHHHHHCC | 42.18 | 21890473 | |
415 | Phosphorylation | LKTQRRKSLPARDGG HHHHHHHCCCCCCCC | 37.46 | 22617229 | |
424 | Phosphorylation | PARDGGFTLEDICML CCCCCCCCHHHHHEE | 32.29 | 28450419 | |
452 | Phosphorylation | DFSLVMESSPGATGS CEEEEEECCCCCCCC | 24.60 | 24275569 | |
462 | Phosphorylation | GATGSFTYEAVELVP CCCCCEEEEEEEEEC | 10.40 | - | |
462 (in isoform 3) | Phosphorylation | - | 10.40 | 22210691 | |
474 (in isoform 3) | Phosphorylation | - | 30.24 | 22210691 | |
481 | Phosphorylation | TQAAWRKSHSSSPQS CHHHHHHHCCCCCCC | 21.74 | 25159151 | |
483 | Phosphorylation | AAWRKSHSSSPQSVL HHHHHHCCCCCCCCC | 39.33 | 27732954 | |
484 | Phosphorylation | AWRKSHSSSPQSVLW HHHHHCCCCCCCCCC | 40.38 | 25849741 | |
485 | Phosphorylation | WRKSHSSSPQSVLWN HHHHCCCCCCCCCCC | 29.94 | 25159151 | |
488 | Phosphorylation | SHSSSPQSVLWNRPQ HCCCCCCCCCCCCCC | 23.67 | 27732954 | |
497 | Phosphorylation | LWNRPQPSEDRLPSQ CCCCCCCCCCCCCCH | 47.05 | 27732954 | |
503 | Phosphorylation | PSEDRLPSQQGLAEA CCCCCCCCHHHHHHH | 39.46 | 17924679 | |
512 | Phosphorylation | QGLAEARSSSSSSSN HHHHHHHCCCCCCCC | 41.44 | 28450419 | |
513 | Phosphorylation | GLAEARSSSSSSSNH HHHHHHCCCCCCCCC | 28.78 | 28450419 | |
514 | Phosphorylation | LAEARSSSSSSSNHS HHHHHCCCCCCCCCC | 35.17 | 25849741 | |
515 | Phosphorylation | AEARSSSSSSSNHSD HHHHCCCCCCCCCCC | 35.87 | 23186163 | |
516 | Phosphorylation | EARSSSSSSSNHSDN HHHCCCCCCCCCCCC | 39.47 | 23186163 | |
517 | Phosphorylation | ARSSSSSSSNHSDNF HHCCCCCCCCCCCCC | 36.79 | 28450419 | |
518 | Phosphorylation | RSSSSSSSNHSDNFF HCCCCCCCCCCCCCC | 40.27 | 23312004 | |
519 | N-linked_Glycosylation | SSSSSSSNHSDNFFR CCCCCCCCCCCCCCC | 40.40 | UniProtKB CARBOHYD | |
521 | Phosphorylation | SSSSSNHSDNFFRMG CCCCCCCCCCCCCCC | 38.20 | 23186163 | |
529 | Phosphorylation | DNFFRMGSSPLEVPK CCCCCCCCCCCCCCC | 21.31 | 29255136 | |
530 (in isoform 2) | Phosphorylation | - | 27.98 | 25849741 | |
530 | Phosphorylation | NFFRMGSSPLEVPKP CCCCCCCCCCCCCCC | 27.98 | 29255136 | |
539 | Phosphorylation | LEVPKPRSVDHPLPG CCCCCCCCCCCCCCC | 40.19 | - | |
547 | Phosphorylation | VDHPLPGSSLSTDYG CCCCCCCCCCCCCCC | 26.60 | 27080861 | |
548 | Phosphorylation | DHPLPGSSLSTDYGS CCCCCCCCCCCCCCC | 32.05 | 27080861 | |
550 | Phosphorylation | PLPGSSLSTDYGSWQ CCCCCCCCCCCCCEE | 22.60 | 27080861 | |
551 | Phosphorylation | LPGSSLSTDYGSWQM CCCCCCCCCCCCEEE | 38.23 | 27080861 | |
553 | Phosphorylation | GSSLSTDYGSWQMVT CCCCCCCCCCEEEEC | 17.10 | 27080861 | |
555 | Phosphorylation | SLSTDYGSWQMVTGC CCCCCCCCEEEECCC | 14.12 | 27080861 | |
573 | Phosphorylation | QERAVLHTDSSLPFS CCEEEEECCCCCCCC | 33.15 | 28450419 | |
575 | Phosphorylation | RAVLHTDSSLPFSFP EEEEECCCCCCCCCC | 34.62 | 28450419 | |
576 | Phosphorylation | AVLHTDSSLPFSFPD EEEECCCCCCCCCCC | 42.76 | 26657352 | |
580 | Phosphorylation | TDSSLPFSFPDELPN CCCCCCCCCCCCCCC | 33.65 | 28450419 | |
606 | Phosphorylation | TRLQEVRSAFLAAYS HHHHHHHHHHHHHHH | 28.66 | 17924679 | |
613 | Phosphorylation | SAFLAAYSSTVGLRA HHHHHHHHCCCCCEE | 18.14 | 17924679 | |
615 | Phosphorylation | FLAAYSSTVGLRAVA HHHHHHCCCCCEEEC | 16.80 | 17924679 | |
624 | Phosphorylation | GLRAVAPSPSGAIGG CCEEECCCCCCHHHH | 23.20 | 21712546 | |
626 | Phosphorylation | RAVAPSPSGAIGGLL EEECCCCCCHHHHHH | 45.23 | 28102081 | |
638 | Methylation | GLLEQFARGVGLRSI HHHHHHHHHCCCHHH | 41.43 | 24129315 | |
644 | Phosphorylation | ARGVGLRSISSNAL- HHHCCCHHHCCCCC- | 31.68 | 28102081 | |
646 | Phosphorylation | GVGLRSISSNAL--- HCCCHHHCCCCC--- | 20.84 | 28102081 | |
647 | Phosphorylation | VGLRSISSNAL---- CCCHHHCCCCC---- | 25.18 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MTMRE_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTMRE_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTMRE_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
160150 | Myopathy, centronuclear, 1 (CNM1) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-194, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-580 AND SER-624, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-606; SER-613 ANDTHR-615, AND MASS SPECTROMETRY. |